Cytology, ThinPrep Pap Test with Reflex to Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep
FDA-approved test for routine 3-year interval cervical cancer screening test in all women ≥21 years. Preferred cotesting panel is Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk by Transcription-Mediated Amplification (TMA) with Reflex to HPV Genotypes 16 and 18/45 by TMA, ThinPrep (for routine cotesting in women over 30) (2000136).
Microscopy/Qualitative Nucleic Acid Amplification
1-7 days, if reflexed, add 2 days
Transport cervical specimen in the original collection kit.
Specimens not collected in a ThinPrep Pap Test collection kit or specimens submitted in an expired collection kit.
Ambient: 3 weeks; Refrigerated: 3 weeks; Frozen: Unacceptable
Refer to report.
No compliance statements are in use for this test.
In addition to the ThinPrep Pap Test, Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (ARUP test code 3003005) will be performed and reported under a separate accession. Additional charges apply. The Pap Test is a screening test for cervical cancer and its precursors with an inherent false-negative rate.
88142; if reviewed by pathologist add 88141. If reflexed, add 87624
|Component Test Code*||Component Chart Name||LOINC|
|2000554||ThinPrep Pap Specimen Source|
- Pap Smear
- Pap Test
- Thin Prep Pap with reflex to HPV HR E6/E7
- Thin Prep reflex HPV
- ThinPrep Pap
- ThinPrep Pap Test with reflex to HR HPV
- ThinPrep Reflex to HPV